Cargando…
Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
Autores principales: | Alenazy, Leila A., Hinther, Kelsey, AlMuhizi, Faisal, Fein, Michael, Tsoukas, Christos, Ben-Shoshan, Moshe, Copaescu, Ana M., Isabwe, Ghislaine Annie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181631/ https://www.ncbi.nlm.nih.gov/pubmed/35690371 http://dx.doi.org/10.1016/j.jaip.2022.05.027 |
Ejemplares similares
-
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience
por: ALMuhizi, Faisal, et al.
Publicado: (2022) -
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose
por: AlMuhizi, Faisal, et al.
Publicado: (2022) -
REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS
por: AlOtaibi, I., et al.
Publicado: (2022) -
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
por: AlOtaibi, Ibtihal, et al.
Publicado: (2023) -
Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
por: Picard, Matthieu, et al.
Publicado: (2022)